Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis

Patients with advanced cardiac immunoglobulin light chain (AL) amyloidosis have a poor prognosis. Early hematologic and cardiac responses can prolong survival, but predictors of these outcomes have yet to be clarified. We report on 142 patients with newly diagnosed stage IIIb AL amyloidosis. After a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gustine, Joshua N., Staron, Andrew, Mendelson, Lisa, Joshi, Tracy, Gopal, Deepa M., Siddiqi, Omar K., Ruberg, Frederick L., Sanchorawala, Vaishali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582303/
https://www.ncbi.nlm.nih.gov/pubmed/37581513
http://dx.doi.org/10.1182/bloodadvances.2023010324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582303/
https://www.ncbi.nlm.nih.gov/pubmed/37581513
http://dx.doi.org/10.1182/bloodadvances.2023010324

Ejemplares similares